Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
have a mark where injection was given and it was very painful; have a mark where injection was given and it was very painful; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 04Sep2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Every booster pfizer (Primary Immunization series complete; Dose number unknown), for Covid-19 immunisation. The following information was reported: VACCINATION SITE REACTION (non-serious), VACCINATION SITE PAIN (non-serious), outcome "unknown" and all described as "have a mark where injection was given and it was very painful". Additional information: The patient just got a covid Comirnaty vaccine. Her last one was 04Sep2024. The patient would like to know why the needle was so big this time. Usually she barely feel the injection. She had had every booster pfizer has put out. This time she had a mark where injection was given and it was very painful. She watched the person gave on to her husband and the needle was so long she was shocked. The patient loved the small ones. She just got a Dtap and it was small and hardly felt it." The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.